Home/Biosimilar Atlas/Somatropin/LG Life Sciences somatropin

LG Life Sciences somatropin

Somatropin biosimilar developed by LG Life Sciences. Reference product Genotropin (Omnitrope's reference); also Norditropin, Humatrope, Saizen.

Brands by market: Brand not published by CDSCO (India, import) · Commercial partner or holder: LG Life Sciences (import) · Company profile
FDANot listed
EMANot listed
MHRANot listed
PMDANot listed
HCNot listed
CDSCOAug 2002permitted
EDENot listed
Approved or registered in 1 of 7 markets
Connections
SomatropinmoleculeLG Life Sciencesdeveloper1 of 7markets0trials behind it1other products, same developer4rival developers in its markets

About LG Life Sciences somatropin

LG Life Sciences of Korea has held an Indian import permission for somatropin since 2002, one of the earliest biologic import permissions in the published lists, with a sustained-release form added in 2013.

Status by market

FDA

United States

Not listed by FDA.

EMA

European Union

Not listed by EMA.

MHRA

United Kingdom

Not listed by MHRA.

PMDA

Japan

Not listed by PMDA.

HC

Canada

Not listed by HC.

CDSCO

India

Central Drugs Standard Control OrganisationApproved
Brand
Not published by CDSCO (INN only)
Holder or applicant
L.G. Chemicals (LG Life Sciences)
Pathway
Import and marketing permission
Approved
Aug 2002
Application or permission
Import permission; sustained-release form 20 December 2013
Indications as licensed
Growth failure in children, including chronic renal insufficiency
Presentations
4 IU vial; sustained-release vial (2013)
Source
S013 (CDSCO) · checked Sep 2026
EDE

United Arab Emirates

Not listed by EDE.

Other developers in the same markets

Where LG Life Sciences somatropin holds an approval, these are the other somatropin biosimilars approved in that market.

MarketRivalsDevelopers (product)
CDSCO4Not stated in the CDSCO list (Cipla somatropin), Reliance Life Sciences (Reliance Life Sciences somatropin), SciGen (SciGen somatropin), USV (USV somatropin)

Same developer, other molecules

Other biosimilars in the Atlas developed by LG Chem: LG Life Sciences insulin glargine.

Chronology

Sources

All somatropin biosimilars

Planning somatropin biosimilar development?

EvySaif can help assess your regulatory pathway, clinical evidence requirements and market-entry strategy across India, UAE and other target markets.

Talk to a biosimilar regulatory consultant
Data current to September 2026.